APRIL CLAXTON: Open Payments
NPI 1821731084 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 124 payments from 27 companies in 2025. Trend: 2023 $2,578 · 2024 $1,914 · 2025 $2,205
Food & beverage: $2,205
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 9 | $418 |
| Neurocrine BioSciences, Inc. | 13 | $228 |
| Teva Pharmaceuticals USA, Inc. | 14 | $205 |
| ABBVIE INC. | 25 | $196 |
| UCB, Inc. | 8 | $174 |
| SK Life Science, Inc. | 11 | $138 |
| Lundbeck LLC | 8 | $138 |
| Eisai Inc. | 5 | $88 |
| Merz Pharmaceuticals, LLC | 4 | $85 |
| ACADIA Pharmaceuticals Inc | 3 | $62 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, INGREZZA, AUSTEDO XR, VYEPTI, Leqembi, QULIPTA, Nayzilam, Xeomin.
Industry payments across OK — which companies pay providers there.
